Sections
Title | Starting Page | Number of Pages |
---|
Table of Contents | 2 | 6 |
List of Tables | 5 | 2 |
List of Figures | 7 | 1 |
AstraZeneca Plc, Medical Equipment, Deals By Year, 2010 to YTD 2016 | 7 | 2 |
AstraZeneca Plc, Medical Equipment Deals By Type, 2010 to YTD 2016 | 9 | 1 |
AstraZeneca Plc, Medical Equipment, Deals By Region, 2010 to YTD 2016 | 10 | 1 |
AstraZeneca Plc, Medical Equipment, Deals By Market, 2010 to YTD 2016 | 11 | 1 |
AstraZeneca Plc, Medical Equipment, Deals Summary, 2010 to YTD 2016 | 12 | 4 |
AstraZeneca Plc, Medical Equipment, Deal Details | 16 | 56 |
Venture Financing | 16 | 1 |
Definiens Raises USD20.3 Million in Venture Financing Round | 16 | 2 |
CeraPedics Raises US$19 Million In Series C Financing | 18 | 2 |
Definiens Raises US$13 Million In Venture Financing | 20 | 2 |
Ambit Biosciences Secures US$30 Million In Series D-2 Financing | 22 | 3 |
Partnerships | 25 | 1 |
AstraZeneca Enters into Agreement with Genedata | 25 | 1 |
Neoprobe Enters Into Licensing Agreement With AstraZeneca | 26 | 2 |
AgPlus Diagnostics Enters into Agreement with AstraZeneca | 28 | 1 |
Indivumed Partners with Definiens | 29 | 1 |
Foundation Medicine Enters into Agreement with AstraZeneca | 30 | 1 |
MedImmune Enters into Agreement with Genisphere | 31 | 1 |
Definiens Partners with MolecularMD | 32 | 1 |
Human Longevity Partners with AstraZeneca | 33 | 1 |
PROOF Centre Partners with AstraZeneca | 34 | 1 |
Labcyte Enters into Agreement with AstraZeneca | 35 | 1 |
HighRes Biosolutions Enters into Agreement with AstraZeneca | 36 | 1 |
AstraZeneca Enters into Research Agreement with Sutter Health | 37 | 1 |
Myriad Genetics Expands Agreement with AstraZeneca | 38 | 1 |
Illumina Partners with AstraZeneca, Janssen and Sanofi to Develop NGS-Based Oncology Test System | 39 | 2 |
AstraZeneca Enters into Co-Development Agreement with Qiagen | 41 | 1 |
AstraZeneca Enters into Co-Development Agreement with Roche | 42 | 1 |
Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK | 43 | 1 |
Ventana Medical Enters into Co-Development Agreement with MedImmune | 44 | 1 |
Definiens Enters Into Agreement With Metamark For ProMark Prognostic Test | 45 | 1 |
Myriad Genetics Expands Agreement with AstraZeneca for Olaparib | 46 | 1 |
Oxford Cancer Biomarkers Enters Into Agreement With AstraZeneca For Biomarker Discovery | 47 | 1 |
AstraZeneca Enters Into Research Agreement With Karolinska Institutet | 48 | 1 |
Metamark Genetics Enters Into Co-Development Agreement With Definiens | 49 | 1 |
Life Technologies, Oxford Biomedical Research Centre, AstraZeneca And ORD Enter Into Co-Development Agreement | 50 | 1 |
Leica Microsystems Enters Into Co-Marketing Agreement With Definiens | 51 | 2 |
Definiens Enters Into An Agreement With Cernostics | 53 | 1 |
Advanced Cell Diagnostics Enters Into Co-Development Agreement With Definiens | 54 | 1 |
Royal Philips Electronics Enters Into Agreement With Definiens | 55 | 1 |
aycan Digitalsysteme Enters Into Technology Integration Agreement With Definiens For Software Solution To Detect Lung Tumors | 56 | 1 |
Thermo Fisher Scientific, Tokyo Medical University, Lund University And AstraZeneca Form Joint Venture | 57 | 1 |
Royal Philips Electronics Signs Agreement With Definiens | 58 | 1 |
AstraZeneca Enters Into Co-Development Agreement With Dako Denmark | 59 | 1 |
Merger | 60 | 1 |
AstraZeneca Rumored To Merge With Amgen | 60 | 1 |
Debt Offering | 61 | 1 |
AstraZeneca Prices Private Placement of 0.875% Notes Due 2021 | 61 | 1 |
Acquisition | 62 | 1 |
Pfizer May Increase Bid to Acquire AstraZeneca | 62 | 2 |
MedImmune Acquires Definiens for USD150 Million | 64 | 2 |
AstraZeneca Rumored To Acquire Forest Labs For US$15 Billion | 66 | 1 |
Celltrion Chairman Jung Jin Seo Plans To Sell Controlling Stake In The Company | 67 | 2 |
AstraZeneca To Acquire Remaining 10% Stake In Astrazeneca Pharma India | 69 | 1 |
DENTSPLY International Acquires Astra Tech From AstraZeneca For US$1,800 Million | 70 | 2 |
AstraZeneca Plc - Key Competitors | 72 | 1 |
Key Employees | 73 | 2 |
Locations And Subsidiaries | 75 | 6 |
Head Office | 75 | 1 |
Other Locations &Subsidiaries | 75 | 6 |
Recent Developments | 81 | 1 |
Strategy And Business Planning | 81 | 1 |
Apr 04, 2016: Heptares Joins Pharma Consortium Applying State of the Art Cryo-Electron Microscopy to Advance Structure Based Drug Discovery | 81 | 1 |
Dec 14, 2015: AZ Investment Gives Local Economy Early Christmas Present | 82 | 1 |
Sep 11, 2015: AstraZeneca purchases US biologics manufacturing facility to support growing pipeline | 83 | 1 |
Jul 30, 2015: Charles River Laboratories and AstraZeneca Renew Strategic Partnership Agreement | 84 | 1 |
Jun 10, 2015: Vall d Hebron Institute of Oncology and AstraZeneca form an oncology alliance | 85 | 1 |
Feb 26, 2015: AstraZeneca to create stand-alone company for small molecule early-stage antibiotic R&D | 86 | 1 |
Financial Announcements | 87 | 1 |
Jul 28, 2016: AstraZeneca: H1 2016 Results | 87 | 12 |
Apr 29, 2016: AstraZeneca announces 1st Quarter 2016 Results | 99 | 11 |
Apr 29, 2016: AstraZeneca Announces Q1 2016 Results | 110 | 2 |
Feb 04, 2016: Full-Year and Q4 2015 Results | 112 | 2 |
Feb 04, 2016: AstraZeneca Full-Year and Q4 2015 Results | 114 | 11 |
Jul 30, 2015: AstraZeneca H1 2015 results | 125 | 7 |
Apr 24, 2015: AstraZeneca first quarter results 2015 | 132 | 8 |
Feb 05, 2015: AstraZeneca Fourth Quarter And Full Year Results 2014 | 140 | 3 |
Corporate Communications | 143 | 1 |
Sep 28, 2016: Change To Astrazeneca Board Of Directors | 143 | 1 |
Aug 24, 2015: AstraZeneca appoints Dr Sean Bohen | 144 | 1 |
Aug 24, 2015: AstraZeneca appoints Dr Sean Bohen as Executive Vice President of Global Medicines Development and Chief Medical Officer | 145 | 1 |
Jun 16, 2015: AstraZeneca appoints Pam Cheng as Executive Vice President, Operations and IT | 146 | 1 |
Jun 10, 2015: AstraZeneca s Chief Medical Officer To Quit Company | 147 | 1 |
Mar 19, 2015: AstraZeneca establishes Scientific Review Board to support clinical trial data transparency commitment | 148 | 2 |
Feb 17, 2015: AstraZeneca announces Non-Executive Board changes | 150 | 1 |
Product News | 151 | 1 |
Apr 17, 2015: Real World Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC | 151 | 1 |
Other Significant Developments | 152 | 1 |
Sep 21, 2016: AstraZeneca Selects LLamasoft as Supply Chain Design Partner of Choice | 152 | 1 |
Jul 23, 2015: Adherium &AstraZeneca Partner to Improve the Lives of Individuals with Respiratory Disease | 153 | 1 |
May 18, 2015: AstraZeneca to invest in new biologics manufacturing facility in S dert lje, Sweden, to support accelerating biologics portfolio | 154 | 1 |
Mar 26, 2015: Helomics Partners with Leading Global Healthcare Companies to Support The 100,000 Genomes Project | 155 | 1 |
Jan 27, 2015: AstraZeneca Chooses Box to Power Enterprise Content Collaboration for All Employees | 156 | 1 |
Jan 05, 2015: AstraZeneca Announces Management Changes | 157 | 1 |
Appendix | 158 | 1 |
Methodology | 158 | 1 |
About GlobalData | 158 | 1 |
Contact Us | 158 | 1 |
Disclaimer | 158 | 1 |